NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
ID: 348507Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348507

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NIAID New Innovator Awards (DP2 Clinical Trial Not Allowed) to support early-stage, creative biomedical researchers proposing innovative research concepts in infectious diseases, immunology, and allergies. This grant opportunity is aimed at postdoctoral researchers and newly independent Early Stage Investigators, allowing them to request up to $300,000 annually for a maximum of five years to foster groundbreaking research that may not yet have sufficient preliminary data. Applications must be submitted through the Grants.gov platform by 5 PM local time on October 10, 2025, and will be evaluated based on significance, innovation, investigator qualifications, and overall impact. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-198-Full-Announcement.html
    PAR-23-198.html
    The NIAID New Innovator Awards, part of the NIH Director's New Innovator Awards program, targets early-stage, creative biomedical researchers with exceptional insights for impactful research in infectious diseases, immunology, and allergies. This funding opportunity (NOFO PAR-23-198) allows for applications proposing innovative, interdisciplinary research concepts. Eligible candidates include postdoctoral researchers or newly independent investigators with Early Stage Investigator status, who may request up to $300,000 annually for a maximum of five years. Submission of applications through the Grants.gov platform is mandated, alongside compliance with the updated NIH policies, including data sharing and resource management. Applications must describe the significance and innovation of proposed research, emphasizing creativity and the potential for major scientific advancements. Peer review evaluates the application’s significance, approach, investigator qualifications, and overall impact to determine funding merit. Key deadlines include the opening date on September 13, 2023, with applications due by 5 PM local time. The goal of this award is to foster groundbreaking research that may not yet have sufficient preliminary data, promoting independence and innovation among emerging researchers in the biomedical field.
    Similar Opportunities
    NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI New Innovator Award, a federal grant aimed at supporting early-stage investigators and postdoctoral candidates in vision research. This opportunity encourages innovative and original research proposals that have the potential to significantly impact the field of vision science, particularly those that explore novel methodologies or interdisciplinary approaches. The program anticipates awarding four grants, with no cost-sharing requirements, and applications are due by May 25, 2026, with an estimated award date of August 2, 2026. For further inquiries, interested applicants can contact Ed Clayton, Ph.D., at 240-987-8255 or via email at Ed.clayton@nih.gov.
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant designed to support postdoctoral fellows in their transition to independent research scientist roles at academic institutions. This grant aims to assist candidates in developing independent research programs and applying for regular research grants, with a focus on enhancing the scientific workforce in biomedical research, particularly in infectious diseases. Eligible applicants include higher education institutions, nonprofits, and government agencies, with funding of up to $150,000 available for the first year and up to $100,000 for the second year, requiring a full-time commitment of at least 75% effort to research activities. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2028.
    NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIH Director's Early Independence Awards (DP5 Clinical Trial Optional), aimed at supporting promising investigators who wish to pursue independent research shortly after completing their terminal doctoral degree or post-graduate clinical training. Eligible applicants must be in a non-independent research position at the time of application and are limited to submitting two applications per institution, with significant institutional commitment required. This funding opportunity, which has an estimated total program funding of $5,100,000 and expects to award approximately nine grants, is part of the High-Risk, High-Reward Research program and encourages applications across all topics relevant to NIH's mission. Interested applicants can reach out to Becky Miller, Ph.D., at earlyindependence@od.nih.gov or by phone at 301-594-9979, with the application process expected to open on September 10, 2025, and close on October 10, 2025.
    NIAID Investigator Initiated Program Project Applications
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the Investigator Initiated Program Project Grants aimed at advancing research in areas pertinent to the NIAID mission. This program encourages small businesses to propose innovative projects that explore the biology and pathogenesis of microbes, immune system functions, and the development of vaccines and therapeutics for infectious and immune-mediated diseases. The grant does not require cost-sharing or matching, with an estimated award date set for December 1, 2026, and applications are due by January 25, 2026. For further inquiries, interested applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Funding Opportunity for NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Director’s Pioneer Award Program, aimed at supporting innovative research projects with significant potential impact in health-related fields. This grant is designed for individual scientists of exceptional creativity who propose bold and high-risk research initiatives, emphasizing the investigator's qualities and the innovativeness of their proposals. The program anticipates awarding approximately $8.1 million across seven grants, with applications expected to open in June 2025 and close in September 2025. Interested applicants can reach out to Dr. Patricia Labosky at PioneerAwards@mail.nih.gov or by phone at 301-594-4863 for further information.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed), aimed at supporting innovative research projects that signify a new direction for early stage investigators (ESIs). Applicants must propose projects without any preliminary data and align their research with the mission of participating NIH Institutes and Centers, while clinical trials are explicitly prohibited. This grant initiative is crucial for fostering innovation among ESIs, allowing them to explore novel research avenues over a maximum project period of five years. Interested applicants should note that the first application deadline is August 25, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Trailblazer Award for New and Early Stage Investigators, a federal grant aimed at fostering innovative biomedical research that integrates engineering with life sciences. This funding opportunity, under the R21 Exploratory/Developmental Research Grant mechanism, allows for up to $400,000 in direct costs over a three-year period for projects that require minimal preliminary data, encouraging high-risk, high-reward research. The initiative is designed to enhance diversity within the research community and is open to a wide range of eligible applicants, including various educational institutions and community organizations. Interested parties should note that the application submission period opens on January 16, 2025, and closes on January 8, 2026; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at supporting the transition of outstanding postdoctoral researchers with clinical doctorate degrees into independent research positions. This program seeks to address the national shortage of physician-scientists by providing a structured pathway that includes up to two years of mentored training followed by up to two years of independent research funding, contingent upon securing a tenure-track position. Eligible applicants include a diverse range of institutions such as higher education institutions, nonprofits, and certain health organizations, with applications evaluated based on the candidate's potential, career development plan, and the scientific merit of the proposed research. Interested parties should note that the application deadline is January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-071.html.
    NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the NIH Director’s Transformative Research Awards, a federal grant opportunity aimed at supporting innovative and unconventional research projects. This program encourages individual scientists or collaborative teams to propose groundbreaking research that has the potential to redefine scientific paradigms or develop transformative technologies, without the need for preliminary data or detailed experimental plans. With an estimated total funding of $8 million and the expectation of awarding seven grants, interested applicants should prepare their proposals in advance, as applications will be solicited starting June 20, 2025, with a closing date of September 3, 2025. For further inquiries, potential applicants can contact Dr. Patricia Labosky at TransformativeAwards@mail.nih.gov or by phone at 301-594-4863.